Updated:
Verve Therapeutics, Inc.
Verve Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001840574, and its reported...
Overview
Verve Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001840574, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-02-27, it reported net income of USD -198,709,000; total assets of USD 647,392,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Verve Therapeutics, Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Boston, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001840574
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2024USD | -$198.7M | $647.4M | $172.6M | -$157.7M | |
| FY2023USD | -$200.1M | $752.7M | $206.2M | -$149.5M | |
| FY2022USD | -$157.4M | $679.2M | $115.4M | -$122.3M | |
| FY2021USD | -$120.3M | $384.1M | $64.3M | -$77.9M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A | ||
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| SC 13G | — | SCHEDULE 13G | |
| 10-Q | 10-Q |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Verve Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.